Sept 25 (Reuters) - SEQUANA MEDICAL NV SEQUA.BR :
* SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN NORTH AMERICAN ALFAPUMP® PIVOTAL STUDY (POSEIDON)
* RESULTS ANTICIPATED BY MID-2021
* STUDY AIMS TO SUPPORT APPROVAL OF ALFAPUMP IN U.S. AND CANADA
* U.S. LAUNCH OF ALFAPUMP PLANNED FOR H1 2022